Skip to content

Efficacy of Prepackaged Low-Residue Diet in the Perioperative Management of Endoscopic Hemorrhoidal Ligation: A Single-Center, Prospective, Randomized, Single-Blind Controlled Trial

Efficacy of Prepackaged Low-Residue Diet in the Perioperative Management of Endoscopic Hemorrhoidal Ligation: A Single-Center, Prospective, Randomized, Single-Blind Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111378
Enrollment
Unknown
Registered
2025-10-30
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoid

Interventions

Prepackaged Low-Residue Diet Group:Participants randomized to the Prepackaged Low-Residue Diet Group will receive the following intervention: Day Before ERBL Procedure: Consume 6 sachets of Yongruiqi
water intake is unrestricted. Day of ERBL Procedure: Take polyethylene glycol electrolyte powder 6 hours before the procedure. One sachet (64.0g) is dissolved in 1 liter of water and consumed at a ra
water intake is unrestricted.
Self-Prepared Low-Residue Diet Group:Participants randomized to the Self-Prepared Low-Residue Diet Group will receive the following intervention: Day Before ERBL Procedure: Consume a conventional low

Sponsors

Shenzhen Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age between 18 and 80 years; 2.Patients undergoing rubber band ligation for Grade I, II, or III internal hemorrhoids; 3.Willingness to participate in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Internal hemorrhoid patients who did not undergo endoscopic rubber band ligation; 2.Patients unable to understand study endpoints or complete data recording forms; 3.Known allergy to ingredients in the prepackaged low-residue diet; 4.Pregnant or breastfeeding women; 5.Patients unable to tolerate hemorrhoid ligation, colonoscopy, or bowel preparation; 6.Patients with severe cardiac, respiratory, neurological, or psychiatric disorders; 7.Individuals lacking legal capacity or self-awareness.

Design outcomes

Primary

MeasureTime frame
Postoperative Pain Intensity;

Secondary

MeasureTime frame
Incidence of postoperative complications;Bowel Cleanliness;Clinical feasibility (including assessment of patient adherence, tolerance, satisfaction, convenience, and acceptability);Short-Term Recurrence Rate;

Countries

China

Contacts

Public ContactZhu Ying

Shenzhen Hospital of Southern Medical University

zhuying1@smu.edu.cn+86 133 8466 2035

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026